Illumina INC:1107104 [22-004231] 01-nextseq 2000 P3 reagents (300 cycles) quotation number: 4453509 02-nextseq 2000 P3 reagents (100 cycles) quotation number: 4453509 03-nextseq 1000/2000 P2…
Ended Awarded
- Contract number
- 75N92B22F20010
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $197,835
Award facts
- Contract value 100% obligated
- $197,834.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6810 Chemicals
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm fixed price delivery order contract to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $197,834.87 contract provides Illumina's NextSeq 2000 and 1000/2000 sequencing reagents to support life science research and diagnostics. This award is not associated with a set-aside program. Illumina has a history of providing sequencing systems and consumables to federal agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Agriculture, and Department of Veterans Affairs. The company also holds an Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery for nucleic acid sequencing needs.
Description
Illumina INC:1107104 [22-004231] 01-nextseq 2000 P3 reagents (300 cycles) quotation number: 4453509 02-nextseq 2000 P3 reagents (100 cycles) quotation number: 4453509 03-nextseq 1000/2000 P2 reagents (300 cycles) V3 quotation number: 4453509 04-N
Quick answers
Who was awarded contract 75N92B22F20010?
75N92B22F20010 was awarded to Illumina, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on August 26, 2022.
How much is contract 75N92B22F20010 worth?
The government has obligated $197,835 on 75N92B22F20010.
Is contract 75N92B22F20010 an order under another contract?
Yes. 75N92B22F20010 is a delivery order under 75N92020D00022, an indefinite delivery contract.
Was contract 75N92B22F20010 competed?
The extent of competition for 75N92B22F20010 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award